Following what many annalists predicted, Verizon is buying Yahoo for $4.83 billion, marking the end of an era for a company that once defined the internet.
Yahoo Inc., based in Sunnyvale, California, is parting with its email service and various still-popular websites devoted to news, finance and sports as well as its advertising tools after falling under pressure from shareholders fed up with a steep downturn in the company’s revenue during the past eight years.
Once the sale is completed early next year, Yahoo will become a holding company for its two stakes in Alibaba Group and Yahoo Japan. Those investments, which were made more than a decade ago, are now worth more than $40 billion before taxes, making them by far the most valuable pieces of Yahoo. The holding company will drop the Yahoo name and adopt a new identify after Verizon takes control of the operating business.
Yahoo still has a patent portfolio that it intends to sell, and about $7.7 billion in cash, however, Verizon is buying Yahoo’s real estate, along with the online operations.
Here is a link from The Wall Street Journal chronicling Yahoo’s stock prices over the years.
Full Content: Chicago Tribune
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas